Ohkura T, Kokuho T, Konishi M, Kameyama K, Takeuchi K. Complete genome
sequences of bovine parainfluenza virus type 3 BN-1 and BN-CE vaccine strains.
Genome Announc 2013, 1(1), e00247-1.
Wakimoto H, Shimodo M, Satoh Y, Kitagawa Y, Takeuchi K, Gotoh B, Ito M. F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin. J Virol 2013; 87(4): 1974-1984.
Matsubara K, Fujino M, Takeuchi K, Iwata S, Nakayama T. A new method for the detection of neutralizing antibodies against mumps virus. PLoS ONE 2013, 8(7),e65281.
Nagata S, Maedera T, Nagata N, Kidokoro M,Takeuchi K, Kuranaga M,Takeda M, Kato A. Comparison of the live attenuated mumps vaccine(Miyahara strain) with its preattenuated parental strain. J Vaccines Immun 2013, 1(2),13-21.
Takeuchi K, Nagata N, Kato SI, Ami Y, Suzaki Y, Suzuki Y, Sato Y, Tsunetsugu-Yokota
Y, Mori K, Van Nguyen N, Kimura H, Nagata K. Wild-type measles virus with
the hemagglutinin protein of the Edmonston vaccine strain retains wild-type
tropism in macaques. J Virol. 2012; 86(6):3027-3037.
Kato SI, Nagata K, Takeuchi K, Cell tropism and pathogenicity of measles virus in monkeys. Front Microbiol. 2012;3:14 Epub 2012 Jan 30.
Yageta Y, Ishii Y, Morishima Y, Masuko H, Ano S, Yamadori T, Itoh K, Takeuchi
K, Yamamoto M, Hizawa N, Role of Nrf2 in host defense against influenza
in chigarette smoke-exposed mice. J Virol. 2011;85(10):4679-4690.
Ito C, Ohgimoto S, Kato S, Sharma L, Ayata M, Komase K, Takeuchi K, Ihara T, Ogura H, Similarity in genome nucleotide sequences between the Schwarz FF-8 and AIK-C measles virus vaccine strains. Microbiol Immunol. 2011;55(7):518-524.
Sugiyama H, Onuki K, Ishige K, Baba N, Ueda T, Matsuda S, Takeuchi K, Onodera M, Nakanuma Y, Yamato M, Yamamoto M, Hyodo I, Shoda J. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells. J Gastroenterol. 2011; 46:779-789.
Takizawa N, Kumakura M, Takeuchi K, Kobayashi N, Nagata K. Sorting of influenza
A virus RNA genome segments after nuclear export. Virology 2010; 401(2):
Ayata, M, Takeuchi K, Takeda M, Ohgimoto S, Kato S, Sharma LB, Tanaka M, Kuwamura M, Ishida H, Ogura H. The F gene of the Osaka-2 strain of measles virus derived from subacute sclerosing panencephalitis is a major determinant of neurovirulence. J Virol. 2010; 84(21): 11189-11199.
Kato S, Ohgimoto S, Sharma LB, Kurazono S, Ayata M, Komase K, Takeda M,
Takeuchi K, Ihara T, and Ogura H. Reduced ability of hemagglutinin of the
CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM. Vaccine
2009; 27(29); 3838-3848.
Okada H, Itoh M, Nagata K and Takeuchi K. Previously unrecognized amino acid substitutions in the hemagglutinin and fusion protein of measles virus modulate cell-cell fusion, hemadsorption, virus growth and penetration rate. J Virol. 2009; 83(17): 8713-8721.
Ninomiya K, Kanayama T, Fujieda N, Nakayama T, Komase K, Nagata K, Takeuchi K. Amino acid substitution at position 464 in the haemagglutinin-neuraminidase protein of a mumps virus Urabe strain enhanced the virus growth in neuroblastoma SH-SY5Y cells. Vaccine 2009; 27(44): 6160-6165.
Sharma LB, Ohgimoto S, Kato S, Kurazono S, Ayata M, Takeuchi K, Ihara T, Ogura H. Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts. J Virol. 2009; 83(22): 11645-11654.
Nishie T, Nagata K, Takeuchi K. The C protein of wild-type measles virus has the ability to shuttle between the nucleus and the cytoplasm. Microbes and Infection. 2007; 9: 344-354.
Takeda M, Ohno S, Seki F, Hashimoto K, Miyajima N, Takeuchi K, and Yanagi
Y. Efficient rescue of measles virus from cloned cDNA using SLAM-expressing
Chinese hamster ovary cells. Virus Res. 2005; 108: 161-165.
Takeuchi K, Takeda M, Miyajima N, Ami Y, Nagata N, Suzaki Y, Shahnewaz J, Kadota S, and Nagata K. Stringent requirement of the C protein of wild-type measles virus for growth both in vitro and in macaque. J Virol. 2005; 79: 7838-7844.
Kadota S, Kanayama T, Miyajima N, Takeuchi K, and Nagata K. Enhancing of measles virus infection by Magnetofection. J Virol Methods. 2005; 128: 61-66.
Miyajima N, Takeda M, Tashiro M, Hashimoto K, Yanagi Y, Nagata K, and Takeuchi
K. Cell tropism of wild-type measles virus is affected by amino acid substitutions
in the P, V and M proteins, or by a truncation in the C protein. J Gen
Virol. 2004; 85: 3001-3006.
Ohno S, Ono N, Takeda M, Takeuchi K, and Yanagi Y. Dissection of measles virus V protein in relation to its ability to block interferon-alpha/beta signal transduction. J Gen Virol. 2004; 85: 2991-2999.
Afzal MA, Osterhaus AD, Cosby SL, Jin L, Beeler J, Takeuchi K, Kawashima
H. Comparative evaluation of measles virus-specific RT-PCR methods through
an international collaborative study. J. Med. Virol. 2003; 70: 171-176.
Takeuchi K, Miyajima N, Nagata N, Takeda M, and Tashiro M. Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM (CD150)-independent mechanism. Virus Res. 2003; 94: 11-16.
Takeuchi K, Kadota S, Takeda M, Miyajima N, and Nagata K. Measles virus V protein blocks interferon-alpha/beta but not interferon-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 2003; 545: 177-182.
Tanabe M, Kurita-Taniguchi M, Takeuchi K, Takeda M, Ayata M, Ogura H, Matsumoto M, Seya T. Mechanism of up-regulation of human Toll-like receptor (TLR)3 secondary to infection of measles virus attenuated strains. Biochem. Biophys. Res. Commun. 2003; 311: 39-48.
Takeuchi K, Takeda M, Miyajima N, Kobune F, Tanabayashi K, and Tashiro
M. Recombinant wild-type and Edmonston strain measles viruses bearing heterologous
H proteins: role of H protein in cell fusion and host cell specificity.
J. Virol. 2002; 76: 4891-4900.
Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, and Yanagi Y. SLAM(CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J. Virol. 2002; 76: 6743-6749.
Takeuchi K, Takeda M, and Miyajima N. Toward understanding the pathogenicity of wild-type measles virus by reverse genetics. Jpn. J. Infect. Dis. 2002; 55: 143-149.
Takeuchi K, Miyajima N, Kobune F, and Tashiro M. Comparative nucleotide
sequence analyses of the entire genomes of B95a cell-isolated and Vero
cell-isolated measles viruses from the same patient. Virus Genes. 2000;
Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, and Tashiro M. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 2000; 74: 6643-6647.
Ohsawa K, Yamada A, Takeuchi K, Watanabe Y, Miyata H, and Sato H. Genetic characterization of parainfluenza virus 3 derived from guinea pigs. J. Vet. Med. Sci. 1998; 60: 919-922.
Takeuchi K, Tanabayashi K, Hishiyama M, and Yamada A. The mumps virus SH
protein is a membrane protein and not essential for virus growth. Virology.
1996; 225: 156-162.
Hishiyama M, Tanabayashi K, Takeuchi K, and Yamada A. Establishment of cell lines stably expressing mumps virus glycoproteins. Jpn. J. Med. Sci. Biol. 1996; 49: 29-38.
Ishikawa K, Nagai H, Katayama K, Tsutsui M, Tanabayashi K, Takeuchi K, Hishiyama M, Saitoh A, Takagi M, Gotoh K, Muramatsu M and Yamada A. Comparison of the entire nucleotide and deduced amino acid sequences of the attenuated hog cholera vaccine strain GPE- and the wild-type parental strain ALD. Arch. Virol. 1995; 140: 1385-1391.
Takeuchi K, Shaughnessy MA, and Lamb RA. Influenza virus M2 protein ion
channel activity is not required to maintain the equine-1 hemagglutinin
in its native form in infected cells. Virology. 1994; 202: 1007-1011.
Takeuchi K and Lamb RA. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J. Virol. 1994; 68: 911-919.
Tanabayashi K, Takeuchi K, Hishiyama M and Yamada A. Effect on fusion induction of point mutations introduced into the F protein of mumps virus. Virology. 1994; 204: 851-853.
Takeuchi K, Tanabayashi K, Okazaki K, Hishiyama M and Yamada A. In vitro
transcription and replication of mumps virus genome. Arch. Virol. 1993;
Tanabayashi K, Takeuchi K, Okazaki K, Hishiyama M and Yamada A. Identification of an amino acid that defines the fusogenicity of mumps virus. J. Virol. 1993; 67: 2928-2931.
Wang C, Takeuchi K, Pinto LH, and Lamb RA. Ion channel activity of influenza A virus M2 protein: Characterization of the amantadine block. J. Virol. 1993; 67: 5585-5594.
Tanabayashi K, Takeuchi K, Okazaki K, Hishiyama M and Yamada A. Expression
of mumps virus glycoproteins in mammalian cells from cloned cDNAs: Both
F and HN proteins are required for cell fusion. Virology. 1992; 187: 801-804.
Okazaki K, Tanabayashi K, Takeuchi K, Hishiyama M, Okazaki K and Yamada A. Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence. Virology. 1992; 188: 926-930.
Boriskin YS, Yamada A, Kaptsova TI, Skvortsova OI, Sinitsyna OA, Takeuchi K, Tanabayashi K and Sugiura A. Genetic evidence for variant selection in the course of dilute passaging of mumps vaccine virus. Res. Virol. 1992; 143: 279-283.
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A and Sugiura A. Variation of nucleotide sequence and transcription of the SH gene among mumps virus strains. Virology. 1991; 181: 364-366.
Tanabayashi K, Takeuchi K, Hishiyama M, Yamada A and Sugiura A. Nucleotide
sequence of the gene encoding the matrix protein of mumps virus (Miyahara
strain). Virus Genes. 1990; 3: 361-365.
Tanabayashi K, Takeuchi K, Hishiyama M, Yamada A, Tsurudome M, Ito Y and Sugiura A. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein. Virology. 1990; 177: 124-130.
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada YK, Yamada A and Sugiura A. Detection and characterization of mumps virus V protein. Virology. 1990; 178: 247-253.
Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M, Takahashi Y and Sugiura A. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequence of the P gene. Vaccine. 1990; 8: 553-557.
Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M and Sugiura A. Sequence
variation of the P gene among mumps virus strains. Virology. 1989; 172:
Nagata K, Takeuchi K and Ishihama A. In vitro synthesis of influenza viral RNA: Biochemical complementation assay of factors required for influenza virus replication. J. Biochem. 1989; 106: 205-208.
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A and Sugiura A. Cloning and Sequencing of the fusion protein gene of mumps virus (Miyahara strain). Nucl. Acids Res. 1989; 17: 5839.
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A and Sugiura A. Cloning and sequencing of the haemagglutinin-neuraminidase gene of mumps virus (Miyahara strain). Nucl. Acids Res. 1989; 17: 5840.
Takeuchi K, Hishiyama M, Yamada A and Sugiura A. Molecular cloning and
sequence analysis of the mumps virus gene encoding the P protein: Mumps
virus P gene is monocistronic. J. Gen. Virol. 1988; 69: 2043-2049.
Yamada A, Takeuchi K and Hishiyama M. Intracellular processing of mumps virus glycoproteins. Virology. 1988; 165: 268-273.
Mori K, Sabe H, Siomi H, Iino T, Tanaka A, Takeuchi K, Hirayoshi K and
Hatanaka M. Expression of a provirus of human T cell leukaemia virus type
I by DNA transfection. J. Gen. Virol. 1987; 68: 499-506.
Kadowaki K, Shibata T, Takeuchi K, Himeno M, Sakai H and Komano T. Identification of a temperature-resistant bacteriophage phiX174 mutant. J. Gen. Virol. 1987; 68: 2443-2447.
Tsuboi K, Hirayoshi K, Takeuchi K, Sabe H, Shimada Y, Ohshio G, Tobe T and Hatanaka M. Expression of the c-myc gene in human gastrointestestinal malignancies. Biochem. Biophys. Res. Com. 1987; 146: 699-704.
Takeuchi K, Nagata K and Ishihama A. In vitro synthesis of influenza viral RNA: Characterization of an isolated nuclear system that supports transcription of influenza viral RNA. J. Biochem. 1987; 101: 837-845.
Iino T, Takeuchi K, Nam SH, Siomi H, Sabe H, Kobayashi N and Hatanaka M. Structural analysis of p28 adult T-cell leukaemia-associated antigen. J. Gen. Virol. 1986; 67: 1373-1379.
Takeuchi K, Kobayashi N, Nam SH, Yamamoto N and Hatanaka M, Molecular cloning of cDNA encoding gp68 of adult T-Cell leukaemia-associated antigen: Evidence for expression of the pXIV region of human T-cell leukaemia virus. J. Gen. Virol. 1985; 66: 1825-1829.
Yamamoto N, Kobayashi N, Takeuchi K, Koyanagi Y, Hatanaka M, Hinuma Y,
Chosa T, Schneider J and Hunsmann G. Characterization of African green
monkey B-cell lines releasing an adult T-cell leukemia-virus-related agent.
Int. J. Cancer. 1984; 34: 77-82.
Okada M, Koyanagi Y, Kobayashi N, Tanaka Y, Nakai M, Sano K, Takeuchi K, Hinuma Y, Hatanaka M and Yamamoto N. In vitro infection of human B lymphocytes with adult T-Cell leukemia virus. Cancer Letters. 1984; 22: 11-21.
Koyanagi Y, Yamamoto Y, Kobayashi N, Hirai K, Konishi H, Takeuchi K, Tanaka Y, Hatanaka M and Hinuma Y. Characterization of human B-cell lines harbouring both adult T-cell leukaemia (ATL) virus and Epstein-Barr virus derived from ATL patient, J. Gen. Virol. 1984; 65: 1781-1789.
Fukui K, Noma T, Takeuchi K, Kobayashi N, Hatanaka M, Honjo T. Origin of adult T-Cell leukemia Virus; Implication for its zoonosis. Mol. Biol. Med. 1983; 1: 447-456.